Cronos Group Inc.

8.72-0.1500-1.69%Vol 2.22M1Y Perf 33.72%
Jun 15th, 2021 16:00 DELAYED
BID8.69 ASK8.73
Open8.91 Previous Close8.87
Pre-Market- After-Market-
 - -  - -%
Target Price
8.11 
Analyst Rating
Hold 3.09
Potential %
-7.00 
Finscreener Ranking
★+     44.07
Insiders Trans % 3/6/12 mo.
-100/-100/-85 
Value Ranking
★★★+     53.67
Insiders Value % 3/6/12 mo.
-100/-100/-99 
Growth Ranking
★★+     50.32
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-99 
Income Ranking
 —    -
Market Cap3.24B 
Earnings Rating
Sell
Price Range Ratio 52W %
34.89 
Earnings Date
5th Aug 2021

Today's Price Range

8.699.13

52W Range

4.9115.83

5 Year PE Ratio Range

-473.90200.60

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
-3.43%
1 Month
19.62%
3 Months
-14.43%
6 Months
7.52%
1 Year
33.72%
3 Years
24.22%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
CRON8.72-0.1500-1.69
AAPL129.64-0.8400-0.64
GOOG2 520.66-6.3800-0.25
MSFT258.36-1.5300-0.59
XOM64.332.26003.64
WFC45.460.31000.69
JNJ164.49-0.8800-0.53
FB336.75-0.0200-0.01
GE13.540.07000.52
JPM155.18-2.3900-1.52
Financial StrengthValueIndustryS&P 500US Markets
4.20
4.40
0.01
0.01
-1 678.00
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
-22.70
-609.80
-594.50
876.80
-30.96
RevenueValueIndustryS&P 500US Markets
53.00M
0.14
93.17
-
Earnings HistoryEstimateReportedSurprise %
Q01 2021-0.08-0.12-50.00
Q04 2020-0.06-0.19-216.67
Q03 2020-0.06-0.0433.33
Q02 2020-0.06-0.19-216.67
Q01 2020-0.070.20385.71
Q04 2019-0.04-0.07-75.00
Q03 2019-0.03-0.0233.33
Q02 2019-0.02-0.0150.00
Earnings Per EndEstimateRevision %Trend
6/2021 QR-0.070.00-
9/2021 QR-0.070.00-
12/2021 FY-0.290.00-
12/2022 FY-0.21-23.53Negative
Next Report Date5th Aug 2021
Estimated EPS Next Report-0.07
Estimates Count6
EPS Growth Next 5 Years %-
Volume Overview
Volume2.22M
Shares Outstanding371.66M
Trades Count13.46K
Dollar Volume50.89M
Avg. Volume4.84M
Avg. Weekly Volume2.84M
Avg. Monthly Volume3.65M
Avg. Quarterly Volume2.89M

Cronos Group Inc. (NASDAQ: CRON) stock closed at 8.72 per share at the end of the most recent trading day (a -1.69% change compared to the prior day closing price) with a volume of 2.23M shares and market capitalization of 3.24B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 665 people. Cronos Group Inc. CEO is Kurt Schmidt.

The one-year performance of Cronos Group Inc. stock is 33.72%, while year-to-date (YTD) performance is 25.65%. CRON stock has a five-year performance of %. Its 52-week range is between 4.91 and 15.83, which gives CRON stock a 52-week price range ratio of 34.89%

Cronos Group Inc. currently has a PE ratio of -9.70, a price-to-book (PB) ratio of 2.11, a price-to-sale (PS) ratio of 62.48, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -15.79%, a ROC of -19.56% and a ROE of -18.28%. The company’s profit margin is -30.96%, its EBITDA margin is -594.50%, and its revenue ttm is $53.00 Million , which makes it $0.14 revenue per share.

Of the last four earnings reports from Cronos Group Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.07 for the next earnings report. Cronos Group Inc.’s next earnings report date is 05th Aug 2021.

The consensus rating of Wall Street analysts for Cronos Group Inc. is Hold (3.09), with a target price of $8.11, which is -7.00% compared to the current price. The earnings rating for Cronos Group Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Cronos Group Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Cronos Group Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 16.72, ATR14 : 0.50, CCI20 : 58.84, Chaikin Money Flow : 0.07, MACD : 0.22, Money Flow Index : 75.42, ROC : 11.51, RSI : 54.97, STOCH (14,3) : 64.65, STOCH RSI : 0.00, UO : 45.55, Williams %R : -35.35), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Cronos Group Inc. in the last 12-months were: Anna Shlimak (Option Excercise at a value of $0), Jason Adler (Option Excercise at a value of $1 976 319), Jason Adler (Sold 1 176 869 shares of value $12 086 088 ), Jeffrey Jacobson (Sold 4 500 shares of value $61 201 ), Michael Gorenstein (Option Excercise at a value of $7 704 786), Michael Gorenstein (Sold 2 422 776 shares of value $21 145 104 ), Puneet Mathur (Option Excercise at a value of $0), Summer Frein (Option Excercise at a value of $0), Todd Kevin Abraham (Buy at a value of $86 756), Todd Kevin Abraham (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (9.09 %)
1 (9.09 %)
3 (27.27 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
1 (9.09 %)
Hold
8 (72.73 %)
8 (72.73 %)
6 (54.55 %)
Moderate Sell
1 (9.09 %)
1 (9.09 %)
1 (9.09 %)
Strong Sell
1 (9.09 %)
1 (9.09 %)
0 (0.00 %)
Summary RatingHold
3.09
Hold
3.09
Moderate Buy
2.45

Cronos Group Inc.

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany.

CEO: Kurt Schmidt

Telephone: +1 416 504-0004

Address: 720 King Street West, Toronto M5V 2T3, ON, CA

Number of employees: 665

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

55%45%

Bearish Bullish

52%48%

News

Stocktwits